Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.50 versus a loss $-3.82 for the same period a year ago. This result fell short of the […]
Greif Inc. (NYSE: GEF) has reported E.P.S. of $1.44 for its first fiscal quarter (ending January 31) versus $1.90 for the same period a year ago — a decline of -24%. E.P.S. were $7.17 for […]
Gogo Inc (NASDAQ: GOGO) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.11 versus $0.22 for the same period a year ago — a decline of -50%. This performance was $-0.02 […]
Barrett Business Services Inc (NASDAQ: BBSI) has reported E.P.S. of $2.20 for its fourth fiscal quarter (ending December 31) versus $1.67 for the same period a year ago — an increase of 32%. Relative to […]
Amicus Therapeutics Inc (NASDAQ: FOLD) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.11 versus a loss $-0.19 for the same period a year ago. This result fell short of […]
Ameresco Inc (NYSE: AMRC) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.65 versus $0.34 for the same period a year ago — an increase of 91%. This result exceeded the […]
Xencor Inc (NASDAQ: XNCR) has reported E.P.S. of $-0.31 for its fourth fiscal quarter (ending December 31) versus $-0.20 for the same period a year ago. Relative to the consensus estimate of $-0.35, this was […]
For its first fiscal quarter (ending January 31), The Bank of Nova Scotia (NYSE: BNS) has reported a 25% increase in E.P.S. from $1.36 a year ago to $1.70 in the current quarter. This performance […]
Safety Insurance Group Inc (NASDAQ: SAFT) has reported E.P.S. of $0.83 for its fourth fiscal quarter (ending December 31) versus $1.68 for the same period a year ago — a decline of -51%. For the […]
For its fourth fiscal quarter (ending December 31), SP Plus Corp (NASDAQ: SP) has reported a -75% decline in E.P.S. from $0.24 a year ago to $0.06 in the current quarter. This performance was $-0.79 […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research